Travere Therapeutics (TVTX) PT Lowered to $36 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce lowered the price target on Travere Therapeutics (NASDAQ: TVTX) to $36.00 (from $42.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
